Practice and safety of allergen-specific immunotherapy for allergic rhinitis in the UK national health service: A report of “real world” clinical practice-Reference-Cited by-同舟云学术

Practice and safety of allergen-specific immunotherapy for allergic rhinitis in the UK national health service: A report of “real world” clinical practice

Published:2017-12-04 Issue:1 Volume:48 Page:89-92
ISSN:0954-7894
Container-title:Clinical & Experimental Allergy
language:en
Short-container-title:Clin Exp Allergy

Author:

Rajakulasingam R. K.¹^ORCID,Farah N.¹,Huber P. A. J.²^ORCID,Durham S. R.³,Clark A. T.⁴,Nasser S. M.⁴,Krishna M. T.⁵^ORCID

Affiliation:

1. Department of Respiratory Medicine/Allergy; Homerton University Hospital NHS Foundation Trust; London UK

2. British Society for Allergy and Clinical Immunology; London UK

3. Department of Allergy; Imperial College London and Royal Brompton Hospital; London UK

4. Allergy Clinic; Addenbrooke's Hospital; Cambridge UK

5. Department of Allergy and Immunology; Heart of England NHS Foundation Trust; Birmingham & Institute of Immunology and Immunotherapy; University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cea.13052/fullpdf

Reference10 articles.

1. CSM update. Desensitising vaccines;Committee on Safety of Medicines;BMJ,1986

2. Systemic reactions and fatalities associated with allergen immunotherapy;Lockey;Ann Allergy Asthma Immunol,2001

3. A new criterion by which to discriminate between patients with moderate allergic rhinitis and patients with severe allergic rhinitis based on the allergic rhinitis and its impact on asthma severity items;Valero;J Allergy Clin Immunol,2007

4. Speaking the same language: the World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System;Cox;J Allergy Clin Immunol,2010

5. SIGN 141 British guideline on the management of asthma 2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce;Clinical and Translational Allergy;2023-06

2. Allergen immunotherapy: The growing role of observational and randomized trial “Real‐World Evidence”;Allergy;2021-08-31

3. BSACI Registry for Immunotherapy (BRIT): Providing safe and effective immunotherapy for allergies and urticaria;Clinical & Experimental Allergy;2021-08

4. Real-life studies in allergen immunotherapy;Current Opinion in Allergy & Clinical Immunology;2021-06-14

5. Peptide allergen‐specific immunotherapy for allergic airway diseases— State of the art;Clinical & Experimental Allergy;2021-02-17